title: Eradication therapy for Helicobacter pylori.
abstract: Eradication therapy for Helicobacter pylori is recommended in a number of clinical conditions. In this article, we discuss the epidemiology and cellular mechanisms that result in antimicrobial resistance, the results of current eradication therapies, and new approaches to the management of Helicobacter pylori infection.
authors.affiliation: Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. nvakil@wisc.edu
authors.forename: Nimish
authors.initials: N
authors.lastname: Vakil
authors.forename: Francis
authors.initials: F
authors.lastname: Megraud
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D024881:Drug Resistance, Bacterial / Q000502:physiology; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D054328:Proton Pump Inhibitors; D055502:Secondary Prevention
chemical_list: D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors